Choice Is Good at Times: The Emergence of [<sup>64</sup>Cu]Cu-DOTATATE–Based Somatostatin Receptor Imaging in the Era of [<sup>68</sup>Ga]Ga-DOTATATE
Abhishek Jha, Mayank Patel, Jorge A. Carrasquillo, Clara Chen, Corina Millo, Roberto Maass‐Moreno, Alexander Ling, Frank I. Lin, Ronald M. Lechan, Thomas A. Hope, David Taïeb, A. Cahid Civelek, Karel Pacák
Abstract
Somatostatin receptor (SSTR) imaging has brought about impactful changes in clinical management of neuroendocrine tumors (NETs), including pheochromocytoma and paraganglioma (PPGL) ([ 1 ][1] , [ 2 ][2]). It allows tumor detection and disease characterization and is mandatory for selecting patients
Topics & Concepts
Somatostatin receptorNeuroendocrine tumorsPheochromocytomaSomatostatinParagangliomaMedicineEndocrinologyInternal medicineCancer researchChemistryNuclear medicinePathologyNeuroendocrine Tumor Research AdvancesAdrenal and Paraganglionic TumorsNeuroblastoma Research and Treatments